Severe Pain Due to Paraspinal Abscess Formation in Two Patients with Squamous-Cell Carcinoma of the Head and Neck after Multimodal Treatment Including Cetuximab

Standard

Severe Pain Due to Paraspinal Abscess Formation in Two Patients with Squamous-Cell Carcinoma of the Head and Neck after Multimodal Treatment Including Cetuximab. / Gerlach, Christina; Pretzell, Ina; Lieberknecht, Elisabeth; Mattyasovszky, Stefan; Weber, Martin.

In: ONCOL RES TREAT, Vol. 41, No. 6, 2018, p. 395-398.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{d70f2a1a39514b898c22f60137aad2ef,
title = "Severe Pain Due to Paraspinal Abscess Formation in Two Patients with Squamous-Cell Carcinoma of the Head and Neck after Multimodal Treatment Including Cetuximab",
abstract = "BACKGROUND: Patients with squamous-cell carcinoma of the head and neck (SCCHN) on palliative therapy usually have a bad prognosis and suffer from various symptoms. With increasing use of targeted agents in cancer patients at the end of life, the correct assignment of therapy-related symptoms becomes increasingly difficult as cancer-related symptoms usually increase as well.CASE REPORT: We report on 2 cases of patients with SCCHN who received multimodal treatment including palliative therapy with cetuximab. Both patients developed severe thoracic and cervicothoracic pain following treatment. In both cases, extensive paraspinal abscess formation proved to be the underlying cause. One patient was treated conservatively; the other one had to undergo surgical intervention.CONCLUSIONS: Awareness of multifaceted therapy-related complications is mandatory when patients receive multimodal treatment including targeted therapies. Unexplained pain syndromes in this context should raise suspicions concerning possible infectious complications and should lead to early use of magnetic resonance imaging.",
keywords = "Abscess/complications, Aged, Antineoplastic Agents, Immunological/adverse effects, Carcinoma, Squamous Cell/therapy, Cetuximab/adverse effects, Combined Modality Therapy, Female, Head and Neck Neoplasms/therapy, Humans, Male, Middle Aged, Pain/diagnosis, Palliative Care/methods, Severity of Illness Index, Spinal Diseases/complications",
author = "Christina Gerlach and Ina Pretzell and Elisabeth Lieberknecht and Stefan Mattyasovszky and Martin Weber",
note = "{\textcopyright} 2018 S. Karger GmbH, Freiburg.",
year = "2018",
doi = "10.1159/000486758",
language = "English",
volume = "41",
pages = "395--398",
journal = "ONCOL RES TREAT",
issn = "2296-5270",
publisher = "S. Karger AG",
number = "6",

}

RIS

TY - JOUR

T1 - Severe Pain Due to Paraspinal Abscess Formation in Two Patients with Squamous-Cell Carcinoma of the Head and Neck after Multimodal Treatment Including Cetuximab

AU - Gerlach, Christina

AU - Pretzell, Ina

AU - Lieberknecht, Elisabeth

AU - Mattyasovszky, Stefan

AU - Weber, Martin

N1 - © 2018 S. Karger GmbH, Freiburg.

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Patients with squamous-cell carcinoma of the head and neck (SCCHN) on palliative therapy usually have a bad prognosis and suffer from various symptoms. With increasing use of targeted agents in cancer patients at the end of life, the correct assignment of therapy-related symptoms becomes increasingly difficult as cancer-related symptoms usually increase as well.CASE REPORT: We report on 2 cases of patients with SCCHN who received multimodal treatment including palliative therapy with cetuximab. Both patients developed severe thoracic and cervicothoracic pain following treatment. In both cases, extensive paraspinal abscess formation proved to be the underlying cause. One patient was treated conservatively; the other one had to undergo surgical intervention.CONCLUSIONS: Awareness of multifaceted therapy-related complications is mandatory when patients receive multimodal treatment including targeted therapies. Unexplained pain syndromes in this context should raise suspicions concerning possible infectious complications and should lead to early use of magnetic resonance imaging.

AB - BACKGROUND: Patients with squamous-cell carcinoma of the head and neck (SCCHN) on palliative therapy usually have a bad prognosis and suffer from various symptoms. With increasing use of targeted agents in cancer patients at the end of life, the correct assignment of therapy-related symptoms becomes increasingly difficult as cancer-related symptoms usually increase as well.CASE REPORT: We report on 2 cases of patients with SCCHN who received multimodal treatment including palliative therapy with cetuximab. Both patients developed severe thoracic and cervicothoracic pain following treatment. In both cases, extensive paraspinal abscess formation proved to be the underlying cause. One patient was treated conservatively; the other one had to undergo surgical intervention.CONCLUSIONS: Awareness of multifaceted therapy-related complications is mandatory when patients receive multimodal treatment including targeted therapies. Unexplained pain syndromes in this context should raise suspicions concerning possible infectious complications and should lead to early use of magnetic resonance imaging.

KW - Abscess/complications

KW - Aged

KW - Antineoplastic Agents, Immunological/adverse effects

KW - Carcinoma, Squamous Cell/therapy

KW - Cetuximab/adverse effects

KW - Combined Modality Therapy

KW - Female

KW - Head and Neck Neoplasms/therapy

KW - Humans

KW - Male

KW - Middle Aged

KW - Pain/diagnosis

KW - Palliative Care/methods

KW - Severity of Illness Index

KW - Spinal Diseases/complications

U2 - 10.1159/000486758

DO - 10.1159/000486758

M3 - SCORING: Journal article

C2 - 29734190

VL - 41

SP - 395

EP - 398

JO - ONCOL RES TREAT

JF - ONCOL RES TREAT

SN - 2296-5270

IS - 6

ER -